New treatment protocol approved for HIV-1

A new treatment protocol approved for HIV-1.

A new complete regimen for the treatment of #HIV-1, known as Cabenuva (cabotegravir and rilpivirine, injectable formulation) has been approved few days ago. This U.S. Food and Drug Administration  first approved injectable,  complete regimen in adults, will now replace the current ARV regimen, in those people with decreased viral load on a stable ARV regimen with no history of "treatment failure" or possible resistance to cabotegravir or rilpivirine and shall be administered once every month.

The report clearly stated that "FDA also approved Vocabria (cabotegravir, tablet formulation), which should be taken in combination with oral rilpivirine (Edurant) for one month prior to starting treatment with Cabenuva to ensure the medications are well-tolerated before switching to the extended-release injectable formulation.

The most common adverse reactions with Cabenuva were injection site reactions, fever (pyrexia), fatigue, headache, musculoskeletal pain, nausea, sleep disorders, dizziness and rash. Cabenuva should not be used if there is a known previous hypersensitivity reaction to cabotegravir or rilpivirine, or in patients who are not virally suppressed (HIV-1 RNA greater than 50 copies/Milliliter)".

As evidence based science are emerging on how to manage #HIV, it is pertinent that Youth Global platform on Hiv/aids continue to formatively empower young people, in other to enhance universal youth response to HIV/AIDS. This is because a more informed young population through sharing of evidence based ideas and vital information that prevents exposure or enhances treatment, makes it easier for the young population to improve on public health standards, protect the health system from being overwhelmed by cases, and advance universal healthcare. Hence the rational for Youth Global Platform on HIV/AIDS, an online platform designed by Onyibupet consulting limited to help young people learn more about preventive measures and evidence based treatment protocols on HIV!